Troubles brew at this pharmacy but analysts see up to 100% return in a year

Jubilant Life#39;s performance would be driven by market share gains in key radiopharmaceutical products, a ramp-up in CMO business, capacity additions in finished dosages Life Science Chemical segment and opportunities from the supply of ethanol to government, IDBI Capital said

from Moneycontrol Business News https://ift.tt/2Ns8TEB